1. Home
  2. Analysis
  3. Bydureon
  4. Cabometyx

Bydureon and Cabometyx drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bydureon (exenatide synthetic) and Cabometyx (cabozantinib s-malate). Common drug interactions include diarrhoea among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Bydureon and Cabometyx. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Bydureon?

Bydureon has active ingredients of exenatide synthetic. It is often used in type 2 diabetes. eHealthMe is studying from 24,309 Bydureon users. Check the latest studies of Bydureon.

What is Cabometyx?

Cabometyx has active ingredients of cabozantinib s-malate. eHealthMe is studying from 35,069 Cabometyx users. Check the latest studies of Cabometyx.

On Jul, 29, 2026

11 people who take Bydureon and Cabometyx together, and have interactions are studied.

Bydureon and Cabometyx drug interactions.

What are the common drug interactions of Bydureon and Cabometyx, by gender? *:

female:

  1. Diarrhoea
  2. Nausea (feeling of having an urge to vomit)
  3. Arthralgia (joint pain)
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Blood pressure increased
  6. Constipation
  7. Dizziness
  8. Fatigue (feeling of tiredness)
  9. Headache (pain in head)
  10. Hepatic enzyme increased

male:

  1. Fatigue (feeling of tiredness)
  2. Paraplegia (paralysis of the legs and lower body)
  3. Pneumonia
  4. Rash
  5. Dysgeusia (disorder of the sense of taste)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Metastases to central nervous system (cancer spreads to central nervous system)
  8. Oral discomfort (pain or irritation in mouth)
  9. Renal impairment (severely reduced kidney function)
  10. Stomatitis (inflammation of mucous membrane of mouth)

What are the common drug interactions of Bydureon and Cabometyx, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood pressure increased
  2. Fatigue (feeling of tiredness)
  3. Pneumonia
  4. Rash

60+:

  1. Fatigue (feeling of tiredness)
  2. Diarrhoea
  3. Joint swelling
  4. Nasal ulcer (ulcer of nose)
  5. Pain in extremity
  6. Rash macular (small, flat red spots)
  7. Skin ulcer
  8. Tooth disorder (tooth disease)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Metastases to central nervous system (cancer spreads to central nervous system)

What are the existing conditions these people have? *

  1. Renal Cell Carcinoma (a kidney cancer): 9 people, 81.82%
  2. Gastrointestinal Stromal Tumor: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Bydureon and Cabometyx?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bydureon and Cabometyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bydureon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cabometyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bydureon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cabometyx and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on exenatide synthetic and cabozantinib s-malate (the active ingredients of Bydureon and Cabometyx, respectively), and Bydureon and Cabometyx (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.